Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

A novel contractile phenotype with cardiac transgenic expression of the human P2X4 receptor.

FASEB journal : official publication of the Federation of American Societies for Experimental Biology - 1 Dec 2001

Hu B, Mei Q B, Yao X J, Smith E, Barry W H, Liang B T

Abstract excerpt

The P2X4 receptor is a newly identified receptor expressed in the heart cell. Its function was elucidated with cardiac transgenic (TG) expression of the receptor by using the myocardium-specific a-myosin heavy chain promoter. The presence of the transgene was determined by polymerase chain reaction by using primers specific to the receptor and the vector linker region, by Southern blotting of the genomic DNA, and...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adenosine Triphosphate
Share to Heart

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Mice, Inbred Strains

Share to Myocardial Contraction

Share to Myocardium

Share to Myosin Heavy Chains

Share to Receptors, Purinergic P2

Share to Thionucleotides

Source

Identifiers

PMID: 11606481
DOI: 10.1096/fj.01-0445fje

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

A novel contractile phenotype with cardiac transgenic expression of the human P2X4 receptor.PMID 11606481Read ↗

Transgenic rat hearts overexpressing SERCA2a show improved contractility under baseline conditions and pressure overloadSemantic proximity Read ↗

Cardiac dysfunction caused by myocardium-specific expression of a mutant thyroid hormone receptor.Semantic proximity Read ↗

Cardiac expression and function of thyroid hormone receptor beta and its PV mutant.Semantic proximity Read ↗

Cardiac-specific overexpression of AT1 receptor mutant lacking G alpha q/G alpha i coupling causes hypertrophy and bradycardia in transgenic mice.Semantic proximity Read ↗

Cardiac-restricted overexpression of the A(2A)-adenosine receptor in FVB mice transiently increases contractile performance and rescues the heart failure phenotype in mice overexpressing the A(1)-adenosine receptor.Semantic proximity Read ↗

Ligand-induced overexpression of a constitutively active beta2-adrenergic receptor: pharmacological creation of a phenotype in transgenic mice.Semantic proximity Read ↗

Targeted expression of a dominant-negative K(v)4.2 K(+) channel subunit in the mouse heart.Semantic proximity Read ↗

Overexpression of the cardiac beta(2)-adrenergic receptor and expression of a beta-adrenergic receptor kinase-1 (betaARK1) inhibitor both increase myocardial contractility but have differential effects on susceptibility to ischemic injury.Semantic proximity Read ↗

Abnormal contractile function in transgenic mice expressing a familial hypertrophic cardiomyopathy-linked troponin T (I79N) mutation.Semantic proximity Read ↗

Enhanced myocardial function in transgenic mice overexpressing the beta 2-adrenergic receptor.Semantic proximity Read ↗

Age-dependent cardiomyopathy and heart failure phenotype in mice overexpressing beta(2)-adrenergic receptors in the heart.Semantic proximity Read ↗

Genetic and phenotypic targeting of beta-adrenergic signaling in heart failure.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.